DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
97	潰瘍性大腸炎	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03648541 (ClinicalTrials.gov)	October 29, 2018	24/8/2018	BI 655130 Long-term Treatment in Patients With moderate-to Severe Ulcerative Colitis	An Open Label, Long Term Safety Trial of BI 65513 (SPESOLIMAB) Treatment in Patients With Moderate to Severely Active Ulcerative Colitis Who Have Completed Previous BI 655130 Trials	Colitis, Ulcerative	Drug: Spesolimab IV infusion;Drug: Spesolimab SC solution for injection	Boehringer Ingelheim	NULL	Recruiting	18 Years	N/A	All	79	Phase 2	United States;Austria;Belgium;Canada;Germany;Italy;Japan;Korea, Republic of;Poland;Russian Federation;Spain;United Kingdom

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT03648541
(ClinicalTrials.gov)

October 29, 2018

24/8/2018

BI 655130 Long-term Treatment in Patients With moderate-to Severe Ulcerative Colitis

An Open Label, Long Term Safety Trial of BI 65513 (SPESOLIMAB) Treatment in Patients With Moderate to Severely Active Ulcerative Colitis Who Have Completed Previous BI 655130 Trials

Colitis, Ulcerative

Drug: Spesolimab IV infusion;Drug: Spesolimab SC solution for injection

Boehringer Ingelheim

NULL

Recruiting

18 Years

N/A

All

Phase 2

United States;Austria;Belgium;Canada;Germany;Italy;Japan;Korea, Republic of;Poland;Russian Federation;Spain;United Kingdom